InsidersTradesSigma
昊帆生物 Stock: price and management transactions · China · SSE / SZSE (CSRC)
Follow the 昊帆生物 share price and the full management transaction log of the company, a listed issuer based in China. Shares are quoted on CN CN, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 昊帆生物 has logged 10 public disclosures. Market capitalisation: €5.5bn. The latest transaction was disclosed on 18 July 2024 (Purchase). Among the most active insiders: 徐杰. Every trade is free.
10
Insider Decl.
0
Thresholds
·
10 ops.
Buy Volume
·
0 ops.
Sell Volume
26Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 15,547 of 25,724 companies
45.5
score / 100
Value26
Quality65
FCF yld-1.8%
Earn yld1.6%
EV/EBITDA43.2x
ROE4.6%
Gross mgn35%
Net mgn19%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 18 July 2024
Declarations10 total
10 of 10 declarations